Host Cell Lipase Chromatography for HCP Removal and PS-80 Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing bioprocessing methods struggle to efficiently separate host cell proteins (HCPs), such as lipases, from production proteins like monoclonal antibodies, and maintain polysorbate-80 (PS-80) stability in drug formulations, which is crucial for meeting regulatory standards and ensuring biopharmaceutical safety and efficacy.

Innovation Solution

The methods involve optimizing chromatographic processes by controlling the separation factor (α) and partition coefficient (Kp) to effectively separate HCPs from production proteins, using conditions where log α is greater than 0.5 and log Kp for lipases is greater than 1.0, and adjusting pH and salt concentrations to achieve this separation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional chromatographic processes are used to separate HCPs from production proteins, then the separation process can be performed, but the separation efficiency is insufficient and HCP levels cannot be reduced to acceptable levels

Engineering Contradiction:
Improveseparation efficiencyVSAvoidHCP removal effectiveness
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent applies parameter changes by systematically optimizing chromatographic conditions including pH (ranging from 4.5-8.0), ionic strength (0.1-1.0 M salt concentration), temperature (4-40°C), and flow rate to achieve a separation factor α > 1.05 and partition coefficient Kp > 1.2, thereby enabling effective separation of HCPs from production proteins

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent implements dynamics by using gradient elution where the mobile phase composition changes continuously during the separation process, starting with low ionic strength buffer and progressively increasing salt concentration to differentially elute HCPs and production proteins based on their binding affinities to the chromatographic resin

Inventive Principle:
Principle #15Dynamics

2Device complexity

If lipases are not removed from production protein formulations, then the formulation can be simplified, but polysorbate-80 stability deteriorates and regulatory requirements are not met

Engineering Contradiction:
Improveformulation complexityVSAvoidpolysorbate-80 stability
Core Design Contradiction:
Device complexityVSStability of the object's composition

Solution Approach 1:

The patent applies the extraction principle by specifically removing lipases from the formulation through chromatographic separation before final formulation, achieving HCP levels < 10 ppm and eliminating the catalytic activity that would otherwise degrade polysorbate-80 and compromise formulation stability

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent implements preliminary anti-action by preemptively removing lipases through optimized chromatographic processes before formulation, preventing the subsequent degradation of polysorbate-80 and eliminating the need for additional stabilizing measures

Inventive Principle:
Principle #9Preliminary anti-action

3Reliability

If chromatographic conditions are optimized for maximum separation, then HCP removal efficiency improves, but process complexity and optimization requirements increase

Engineering Contradiction:
ImproveHCP removal effectivenessVSAvoidprocess optimization complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by conducting extensive pre-experimental characterization of HCP and production protein binding properties under various chromatographic conditions, establishing predictive models for separation factor and partition coefficient that guide subsequent process optimization and reduce trial-and-error requirements

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses an intermediary approach by introducing a characterization phase that measures separation factor α and partition coefficient Kp under standardized conditions, using these intermediate parameters to predict and optimize final separation performance without requiring complete process re-optimization

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces HCP levels, particularly lipases, to less than 1 ppm, and enhances PS-80 stability in production protein formulations, meeting regulatory requirements and improving the quality of biopharmaceuticals.

Implementation Method 1

passing a load fluid comprising the lipase and the production protein through a chromatographic resin

Methodology Applied
Scientific EffectChromatography: Chromatography

Implementation Method 2

separation factor (α) is the ratio of the partition coefficient (Kp) for the lipase to the Kp for the production protein

Methodology Applied
Scientific EffectPartition coefficient:

Data Source

PatentUS20250230185A1Methods of separating host cell lipases from a production protein in chromatographic processes
Publication Date: 2025.07.17 MERCK SHARP & DOHME LLC
  • US20250230185A1 patent drawing
  • US20250230185A1 patent drawing
  • US20250230185A1 patent drawing

AI summary

Provided herein are methods of separating host cell lipases from a production protein in chromatographic processes and methods of improving polysorbate-80 stability in a production protein formulation by separating host cell lipases from the production protein using chromatographic processes. Also provided are pharmaceutical compositions comprising less than 1 ppm of